Novo Nordisk Presses Forward With Oral Semaglutide and Amycretin as CagriSema Nears FDA Verdict
Novo Nordisk awaits FDA decisions on CagriSema and oral Ozempic, expands paediatric GLP-1 approvals, and advances Amycretin for…
European Lithium Presses Forward with Saudi Refinery and Greenland Merger as Timeline Firms Up
European Lithium pursues lithium hydroxide refinery in Saudi Arabia and all-stock merger with Critical Metals Corp for Greenland…